Pharmena S.A.
PHR.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | PLN 35 | PLN 33 | PLN 51 | PLN 43 |
| - Cash | PLN 0 | PLN 0 | PLN 1 | PLN 2 |
| + Debt | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Enterprise Value | PLN 35 | PLN 33 | PLN 50 | PLN 41 |
| Revenue | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| % Growth | 5.4% | -1.8% | 346.6% | – |
| Gross Profit | PLN 0 | -PLN 1 | PLN 0 | PLN 0 |
| % Margin | 84.8% | -175.4% | 76.6% | 85.2% |
| EBITDA | -PLN 1 | -PLN 1 | -PLN 0 | -PLN 1 |
| % Margin | -160% | -219.2% | -112.2% | -1,072.4% |
| Net Income | -PLN 1 | -PLN 1 | -PLN 0 | -PLN 0 |
| % Margin | -169.5% | -181.3% | -124.4% | -134.1% |
| EPS Diluted | 0 | -0.07 | -0.044 | -0.011 |
| % Growth | 100% | -59.5% | -314.2% | – |
| Operating Cash Flow | -PLN 1 | -PLN 1 | -PLN 1 | -PLN 0 |
| Capital Expenditures | -PLN 0 | -PLN 0 | -PLN 9 | -PLN 0 |
| Free Cash Flow | -PLN 1 | -PLN 1 | -PLN 10 | -PLN 0 |